Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population

Department of Metabolic Diseases, Medical College, Jagiellonian University, 15 Kopernika Street, 31-501 Krakow, Poland. mmalecki@cm-uj.krakow.pl

OBJECTIVE: The polymorphisms of two genes have recently been associated with complex forms of type 2 diabetes mellitus (T2DM): calpain 10 and peroxisome proliferator-activated receptor-gamma (PPARgamma). Calpain 10 is a member of a large family of intracellular proteases. It was shown in Mexican-Americans and other populations that variants of three single nucleotide polymorphisms (SNPs), -43, -19, and -63, of this ubiquitously expressed protein influence susceptibility to T2DM. However, substantial differences were shown between ethnic groups in at risk alleles and haplotypes as well as in their attributable risk. Thus, it is important to determine the role of calpain 10 in various populations. AIM: To examine the role of calpain 10 SNPs -43, -19, and -63 in genetic susceptibility to T2DM in a Polish population. METHODS: Overall, 377 individuals were examined: 229 T2DM patients and 148 control individuals. The groups were genotyped for calpain 10 SNP-43, SNP-19, and SNP-63. SNP-19 was examined by electrophoresis of the PCR product on agarose gel by size, while the restriction fragment length polymorphism (RFLP) method was used for the two other markers. Differences in allele, genotype, haplotype, and haplotype combination distribution between the groups were examined by chi(2) test. RESULTS: Distributions of alleles, genotypes, and haplotypes at three loci defined by examined SNPs were not significantly different between the groups. However, the homozygote combination of 121 haplotype was more prevalent in the T2DM group than in the controls (17.9% vs 10.1%, P=0.039). No difference was observed in the 112/121 haplotype distribution. This heterozygous haplotype combination was associated with increased risk of T2DM in several populations. CONCLUSION: The results of our study suggest the association of calpain 10 121/121 haplotype combination created by SNPs -43, -19, and -63 with T2DM in a Polish population. However, we were not able to confirm the previously described role of the heterozygous 112/121 haplotype combination in susceptibility to T2DM.

This article has been cited by other articles:

				M. T. Malecki, A. Undas, K. Cyganek, B. Mirkiewicz-Sieradzka, P. Wolkow, G. Osmenda, M. Walus-Miarka, T. J. Guzik, and J. Sieradzki Plasma Asymmetric Dimethylarginine (ADMA) Is Associated With Retinopathy in Type 2 Diabetes Diabetes Care, November 1, 2007; 30(11): 2899 - 2901. [Full Text] [PDF]

				M. Meier, H. H Klein, J. Kramer, M. Drenckhan, and M. Schutt Calpain inhibition impairs glycogen syntheses in HepG2 hepatoma cells without altering insulin signaling J. Endocrinol., April 1, 2007; 193(1): 45 - 51. [Abstract] [Full Text] [PDF]

				C. Vollmert, S. Hahn, C. Lamina, C. Huth, M. Kolz, A. Schopfer-Wendels, K. Mann, F. Bongardt, J. C. Mueller, F. Kronenberg, et al. Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E836 - E844. [Abstract] [Full Text] [PDF]

				J. Bochenski, G. Placha, K. Wanic, M. Malecki, J. Sieradzki, J. H. Warram, and A. S. Krolewski New Polymorphism of ENPP1 (PC-1) Is Associated With Increased Risk of Type 2 Diabetes Among Obese Individuals Diabetes, September 1, 2006; 55(9): 2626 - 2630. [Abstract] [Full Text] [PDF]

				E. Carlsson, J. Fredriksson, L. Groop, and M. Ridderstrale Variation in the Calpain-10 Gene Is Associated with Elevated Triglyceride Levels and Reduced Adipose Tissue Messenger Ribonucleic Acid Expression in Obese Swedish Subjects J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3601 - 3605. [Abstract] [Full Text] [PDF]

				H. Leipold, M. Knofler, C. Gruber, P. Haslinger, D. Bancher-Todesca, and C. Worda Calpain-10 Haplotype Combination and Association With Gestational Diabetes Mellitus Obstet. Gynecol., June 1, 2004; 103(6): 1235 - 1240. [Abstract] [Full Text] [PDF]

				N. J. Cox, M. G. Hayes, C. A. Roe, T. Tsuchiya, and G. I. Bell Linkage of Calpain 10 to Type 2 Diabetes: The Biological Rationale Diabetes, February 1, 2004; 53(90001): S19 - 25. [Abstract] [Full Text]

				H. Gorgens, P. Schwarz, J. Schulze, and H. K. Schackert LightCycler Assay in the Analysis of Haplotypes of the Type 2 Diabetes Susceptibility Gene CAPN10 Clin. Chem., August 1, 2003; 49(8): 1405 - 1408. [Full Text] [PDF]